博拓生物 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	559.0M	442.0M	1.9B	1.8B	865.0M
Revenue Growth %	26.5%	-76.7%	4.6%	110.2%	--
Total Revenue	559.0M	442.0M	1.9B	1.8B	865.0M
Cost Of Revenue	264.0M	220.0M	885.0M	694.0M	238.0M
+Gross Profit	295.0M	222.0M	1.0B	1.1B	627.0M
Gross Margin %	52.8%	50.2%	53.4%	61.8%	72.5%
Total Operating Cost	388.0M	358.0M	1.0B	859.0M	356.0M
Selling Expenses	30.9M	27.9M	28.5M	22.9M	19.0M
Admin Expenses	55.0M	51.3M	57.6M	46.7M	23.4M
Rd Expenses	63.6M	80.5M	108.0M	61.9M	41.3M
Finance Expenses	-60.1M	-85.8M	-148.0M	1.7M	16.8M
+Operating Income	193.0M	117.0M	914.0M	967.0M	513.0M
Operating Margin %	34.5%	26.5%	48.1%	53.2%	59.3%
Non Operating Income	1.6M	608,100	10,400	2.7M	1.3M
Non Operating Expenses	66,100	1.6M	12.5M	548,900	57,200
Investment Income	6.8M	3.4M	14.8M	227,200	69,000
Fair Value Change Income	257,800	--	64,500	841,200	--
Asset Disposal Income	-334,400	2,300	--	--	-34,900
Asset Impairment Loss	22.8M	55.3M	73.9M	11.5M	4.9M
Other Income	15.1M	29.1M	17.5M	6.3M	3.8M
Income Before Tax	195.0M	116.0M	902.0M	969.0M	514.0M
Income Tax	28.1M	10.6M	128.0M	133.0M	79.4M
+Net Income	167.0M	105.0M	774.0M	836.0M	435.0M
Net Margin %	29.9%	23.8%	40.7%	46.0%	50.3%
Net Income Attributable	170.0M	107.0M	774.0M	834.0M	435.0M
Minority Interest	-2.7M	-1.3M	-70,100	2.2M	-180,400
Eps Basic	1.61	1.00	7.25	9.62	5.44
Eps Diluted	1.61	1.00	7.25	9.62	5.44

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	1.6B	1.9B	1.9B	1.4B	261.0M
Trading Financial Assets	60.3M	--	100.0M	361.0M	--
Accounts Receivable	97.5M	61.9M	38.8M	147.0M	96.3M
Notes And Accounts Receivable	97.5M	61.9M	38.8M	147.0M	96.3M
Prepayments	1.7M	1.3M	4.4M	6.6M	3.9M
Inventory	73.4M	99.3M	135.0M	142.0M	92.4M
Total Current Assets	1.9B	2.1B	2.2B	2.0B	468.0M
Long Term Equity Investment	9.3M	2.8M	--	--	--
Fixed Assets	--	221.0M	228.0M	224.0M	50.0M
Fixed Assets Total	322.0M	221.0M	228.0M	224.0M	50.0M
Construction In Progress	--	39.7M	9.8M	--	88.6M
Construction In Progress Total	87.2M	39.7M	9.8M	--	88.6M
Intangible Assets	275.0M	209.0M	214.0M	20.3M	20.7M
Long Term Deferred Expenses	--	108,300	212,900	292,400	399,000
Total Non Current Assets	724.0M	493.0M	516.0M	399.0M	166.0M
Total Assets	2.6B	2.6B	2.8B	2.4B	634.0M
Short Term Borrowings	440,500	588,800	349,000	5.6M	11.1M
Accounts Payable	56.4M	58.4M	88.7M	224.0M	111.0M
Advance Receipts	--	--	--	--	--
Contract Liabilities	7.4M	47.2M	44.7M	18.6M	8.9M
Total Current Liabilities	179.0M	149.0M	171.0M	318.0M	191.0M
Long Term Borrowings	--	--	--	--	--
Total Non Current Liabilities	11.2M	9.4M	18.2M	5.8M	310,600
Total Liabilities	190.0M	159.0M	189.0M	323.0M	191.0M
Paid In Capital	107.0M	107.0M	107.0M	107.0M	80.0M
Capital Reserve	790.0M	813.0M	815.0M	815.0M	12.2M
Surplus Reserve	53.3M	53.3M	53.3M	53.3M	40.0M
Retained Earnings	1.5B	1.5B	1.6B	1.1B	311.0M
Minority Equity	2.9M	5.5M	1.0M	1.1M	-1.1M
Equity Attributable	2.4B	2.4B	2.6B	2.1B	444.0M
Total Equity	2.4B	2.4B	2.6B	2.1B	443.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	498.0M	322.0M	2.1B	1.8B	818.0M
Tax Refunds Received	15.6M	30.1M	82.2M	72.2M	22.0M
Total Operating Cash Inflow	582.0M	473.0M	2.2B	1.9B	848.0M
Cash Paid For Goods	257.0M	121.0M	1.1B	662.0M	230.0M
Cash Paid To Employees	126.0M	127.0M	172.0M	122.0M	68.2M
Taxes Paid	15.3M	33.6M	226.0M	140.0M	74.7M
Total Operating Cash Outflow	453.0M	342.0M	1.5B	976.0M	402.0M
Operating Cash Flow	129.0M	131.0M	703.0M	908.0M	446.0M
Total Investing Cash Inflow	6.4B	135.0M	566.0M	227,200	51.7M
Total Investing Cash Outflow	7.2B	60.2M	469.0M	600.0M	108.0M
Investing Cash Flow	-838.0M	74.4M	96.7M	-600.0M	-56.1M
Cash From Borrowings	--	239,700	--	5.6M	25.6M
Dividends And Interest Paid	83.6M	235.0M	320.0M	20.9M	100.0M
Debt Repayments	148,300	--	5.3M	11.0M	46.6M
Total Financing Cash Inflow	24.9M	4.4M	--	862.0M	28.6M
Total Financing Cash Outflow	129.0M	254.0M	333.0M	48.5M	154.0M
Financing Cash Flow	-105.0M	-249.0M	-333.0M	813.0M	-125.0M
Net Change In Cash	-803.0M	-32.6M	572.0M	1.1B	247.0M
Ending Cash Balance	1.1B	1.9B	1.9B	1.4B	261.0M
Capex	245.0M	56.4M	179.0M	200.0M	57.7M